Expression and clinical significance of GRIM-19 in lung cancer

Medical Oncology, 05/14/2012

The study found that gene associated with retinoid–interferon–induced mortality–19 (GRIM–19) expression in lung cancer is significantly lower compared to lung inflammation, exhibits a relationship with the histological type and clinical stage of lung cancer, and is a suitable target for the development of new lung cancer therapies.

Print Article Summary Cat 2 CME Report